Expanded Access for Medicare Patients For the first time, Medicare will cover GLP-1 medications for obesity, starting mid-2026
Most of them, about 80%, were taking the GLP-1 for a diabetes indication, not for a weight management indication
Tirzepatide, like all peptides, is susceptible to oxidation
Patients experiencing severe dehydration symptoms (dizziness, decreased urination, confusion) or signs of significant electrolyte disturbance (irregular heartbeat, severe fatigue, numbness or tingling) should seek prompt medical care
Clearly, since the only thing that changed was the pizza and my use of the medication, I avoided pizza, and the problem didn't happen again
Avoid if you are: Always consult a doctor before starting the injection